Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Trofinetide clinical trials
2 selected ClinicalTrials.gov records carrying the official matched intervention Trofinetide (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
2 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 20 selected PubMed records and 2 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT04181723
PeptideScanner retained ClinicalTrials.gov record NCT04181723 at 2026-11-15T21:57:22.404Z. Its registry update date was 2024-04-08, and PeptideScanner's reviewed identity mapping was trofinetide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 8, 2024
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT04279314
PeptideScanner retained ClinicalTrials.gov record NCT04279314 at 2026-11-15T21:57:22.404Z. Its registry update date was 2024-04-11, and PeptideScanner's reviewed identity mapping was trofinetide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- April 11, 2024
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Trofinetide · 2024-04-11
ClinicalTrials.gov record NCT04279314
Completed at the retained observation.
Open attributed record →Trofinetide · 2024-04-08
ClinicalTrials.gov record NCT04181723
Completed at the retained observation.
Open attributed record →